SYM vs TLRY · rev $2.25B vs rev $821.3M
Symbotic Inc (SYM) versus Tilray Inc (TLRY) — a side-by-side from cached financials, not a winner call.
Symbotic Inc (SYM) is a specialty industrial machinery company listed on NASDAQ.
Tilray Inc (TLRY) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported SYM revenue for 2025-09-27 was $2.25B. Net income was -$91.0M. Revenue was up 298.0% from 2024-09-28 to 2025-09-27. SYM currently screens at market cap $24.25B.
Latest reported TLRY revenue for 2025-05-31 was $821.3M. Net income was -$2.18B. Revenue was up 4.1% from 2024-05-31 to 2025-05-31. TLRY currently screens at market cap $573.9M.
SYM currently screens at market cap $24.25B. TLRY currently screens at market cap $573.9M.
Not investment advice. Open the SYM and TLRY stock pages for the full models.
Not investment advice.